US Stock MarketDetailed Quotes

IFRX InflaRx

Watchlist
  • 2.410
  • -0.090-3.60%
Close Jan 3 16:00 ET
  • 2.281
  • -0.129-5.34%
Post 20:01 ET
141.91MMarket Cap-2.40P/E (TTM)

About InflaRx Company

InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a and its receptor C5aR. Its primary product candidate is Vilobelimab. The company was founded by Niels Christoph Riedemann, Renfeng Guo, and Nicolas Fulpius in December 2007 and is headquartered in Jena, Germany.

Company Profile

SymbolIFRX
Company NameInflaRx
Listing DateNov 8, 2017
Issue Price15.00
Founded2007
CEOProfessor Niels Riedemann
MarketNASDAQ
Employees66
Fiscal Year Ends12-31
AddressWinzerlaer Strasse 2
CityJena
ProvinceThueringen
CountryGermany
Zip Code07745
Phone49-36-41-508180

Company Executives

  • Name
  • Position
  • Salary
  • Professor Niels Riedemann
  • Executive Director and Chief Executive Officer
  • --
  • Dr. Thomas Taapken
  • Chief Financial Officer
  • --
  • Dr. Camilla Chong
  • Chief Medical Officer
  • --
  • Professor Dr. Renfeng Guo, M.D.
  • Executive Director and Chief Scientific Officer
  • --
  • Derval O’Carroll
  • Senior Vice President and Global Head, Regulatory Affairs and Compliance
  • --
  • Nicolas Fulpius
  • Non-Executive Chairman of the Board
  • --
  • Hege Hellstrom
  • Director
  • --
  • Anthony Gibney
  • Independent Director
  • --
  • Richard H. Brudnick
  • Independent Director
  • --
  • Mark Kubler
  • Independent Director
  • --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.